Spring House, PA, United States of America

Feifei Yang

This inventor holds 1 USPTO granted patent. Top assignee: Janssen Biotech, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Feifei Yang. Retrieved from https://idiyas.com/inventor/feifei-yang-vi3l5h0s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Feifei Yang: Innovator in Inflammatory Bowel Disease Therapy

Introduction

Feifei Yang is a notable inventor based in Spring House, PA, who has made significant contributions to the field of medical research. His work primarily focuses on developing methods and compositions that enhance the prediction of responses to therapies for inflammatory bowel disease.

Latest Patents

Feifei Yang holds a patent titled "Methods and Compositions for Prediction of Response to a Therapy of an Inflammatory Bowel Disease." This patent represents a crucial advancement in understanding how patients may respond to specific treatments, thereby improving therapeutic outcomes.

Career Highlights

Feifei Yang is currently employed at Janssen Biotech, Inc., a company renowned for its innovative approaches in biotechnology and pharmaceuticals. His role at Janssen allows him to collaborate with other experts in the field, furthering research and development in critical areas of healthcare.

Collaborations

Throughout his career, Feifei has worked alongside esteemed colleagues such as Frederic Baribaud and Carrie Brodmerkel. Their combined expertise contributes to the advancement of research in inflammatory bowel disease and related therapies.

Conclusion

Feifei Yang's contributions to the field of inflammatory bowel disease therapy through his patent and work at Janssen Biotech, Inc. highlight his commitment to improving patient care. His innovative approaches continue to pave the way for advancements in medical research and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…